Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Hercules Capital, Inc. | Director | Common Stock | 59.4K | $1.07M | $18.06 | Aug 6, 2024 | Direct |
PLIANT THERAPEUTICS, INC. | Director | Common Stock (Right to Buy) | 26.8K | $55.7K | $2.08 | Jun 13, 2024 | Direct |
ENVESTNET, INC. | Director | Common Stock | 0 | $0 | $63.15 | Nov 25, 2024 | By trust |
ENVESTNET, INC. | Director | Common Stock | 0 | $0 | $63.15 | Nov 25, 2024 | Direct |
ENVESTNET, INC. | Director | Stock Option (right to buy) | 0 | $0 | $15.34 | Nov 25, 2024 | Direct |